Recombinant Human Apelin protein (GST tag N-Terminus)
Recombinant Human Apelin protein (GST tag N-Terminus)
Be the first to review this product! Submit a review
|
(2 Publications)
Recombinant Human Apelin protein (GST tag N-Terminus) is a Human Full Length protein, in the 1 to 77 aa range, expressed in Wheat germ, suitable for ELISA, WB.
別名を表示する
APEL, APLN, Apelin, APJ endogenous ligand
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human Apelin protein (GST tag N-Terminus) (AB152927)
ab152927 on a 12.5% SDS-PAGE stained with Coomassie Blue.
Reactivity data
配列情報
出荷温度及び保存条件
製品の状態
精製方法
出荷温度
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Apelin acts as an important regulator of cardiovascular functions and fluid homeostasis. It modulates blood pressure and cardiac contractility indicating its role in maintaining cardiovascular health. Apelin operates independently but interacts closely with its receptor APJ forming a functional complex that initiates various intracellular signaling mechanisms. Researchers have noted its significant effects on the vascular system and potential involvement in angiogenesis.
Pathways
Apelin participates in the renin-angiotensin system and influences the nitric oxide signaling pathway. These pathways are important for maintaining vascular tone and pressure as well as for ensuring proper fluid balance in the body. Apelin's actions appear related to the angiotensin II type 1 receptor and endothelial nitric oxide synthase affecting their activity to achieve desired physiological outcomes. This involvement illustrates how apelin bridges different signaling networks to regulate homeostasis.
一般的な情報
機能
Peptide hormone that functions as endogenous ligand for the G-protein-coupled apelin receptor (APLNR/APJ), that plays a role in cadiovascular homeostasis (PubMed : 10525157, PubMed : 22810587, PubMed : 35817871, PubMed : 38428423). Functions as a balanced agonist activating both G(i) protein pathway and beta-arrestin pathway of APLNR (PubMed : 22810587, PubMed : 38428423). Downstream G proteins activation, apelin can inhibit cAMP production and activate key intracellular effectors such as ERKs (PubMed : 22810587, PubMed : 35817871, PubMed : 38428423). On the other hand, APLNR activation induces beta-arrestin recruitment to the membrane leading to desensitization and internalization of the receptor (PubMed : 22810587, PubMed : 38428423). Apelin blunts cardiac hypertrophic induction from APLNR on response to pathological stimuli, but also induces myocardial hypertrophy under normal conditions (PubMed : 22810587, PubMed : 38428423). Apelin-36 dissociates more hardly than (pyroglu)apelin-13 from APLNR (By similarity). Involved in the regulation of cardiac precursor cell movements during gastrulation and heart morphogenesis (By similarity). Has an inhibitory effect on cytokine production in response to T-cell receptor/CD3 cross-linking; the oral intake of apelin in the colostrum and the milk might therefore modulate immune responses in neonates (By similarity). Plays a role in early coronary blood vessels formation (By similarity). Mediates myocardial contractility in an ERK1/2-dependent manner (By similarity). May also have a role in the central control of body fluid homeostasis by influencing vasopressin release and drinking behavior (By similarity).. (Microbial infection) Endogenous ligand for the apelin receptor (APLNR), an alternative coreceptor with CD4 for HIV-1 infection (PubMed : 11090199). Inhibits HIV-1 entry in cells coexpressing CD4 and APLNR (PubMed : 11090199). Apelin-36 has a greater inhibitory activity on HIV infection than other synthetic apelin derivatives (PubMed : 11090199).
配列の類似性
Belongs to the apelin family.
翻訳後修飾
Several active peptides may be produced by proteolytic processing of the peptide precursor.
ターゲットの情報
文献 (2)
Recent publications for all applications. Explore the full list and refine your search
Oxidative medicine and cellular longevity 2023:5012474 PubMed36785790
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cardiovascular medicine 9:956041 PubMed36017090
2022
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com